These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17886101)

  • 1. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation.
    Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K
    Pathology; 2007 Oct; 39(5):504-11. PubMed ID: 17886101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
    Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
    Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
    Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
    Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia.
    Favaloro EJ; Bonar R; Kershaw G; Mohammed S; Duncan E; Marsden K;
    Haemophilia; 2010 Jul; 16(4):662-70. PubMed ID: 20070382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pearls and pitfalls in factor inhibitor assays.
    Adcock DM; Favaloro EJ
    Int J Lab Hematol; 2015 May; 37 Suppl 1():52-60. PubMed ID: 25976961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality issues in laboratory haemostasis.
    Preston FE; Lippi G; Favaloro EJ; Jayandharan GR; Edison ES; Srivastava A
    Haemophilia; 2010 Jul; 16 Suppl 5():93-9. PubMed ID: 20590863
    [No Abstract]   [Full Text] [Related]  

  • 8. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control in coagulation testing.
    Plebani M; Sanzari MC; Zardo L
    Semin Thromb Hemost; 2008 Oct; 34(7):642-6. PubMed ID: 19085764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ; Bonar R; Marsden K
    Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
    Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
    Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory.
    Favaloro EJ; Mohammed A; Coombs R; Mehrabani PA
    Br J Biomed Sci; 1995 Dec; 52(4):243-8. PubMed ID: 8555777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program.
    Wong R; Wilson R; Pollock W; Steele R; Gillis D
    Pathology; 2004 Apr; 36(2):174-81. PubMed ID: 15203755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External quality assessment of factor VIII inhibitor assays.
    Bonar RA; Favaloro EJ; Marsden K
    Semin Thromb Hemost; 2013 Apr; 39(3):320-6. PubMed ID: 23436565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age, and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S, and antithrombin deficiency and the potential high risk of a false positive diagnosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
    Lab Hematol; 2005; 11(3):174-84. PubMed ID: 16174603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired functional coagulation inhibitors: review on epidemiology, results of a wet-workshop on laboratory detection, and implications for quality of inhibitor diagnosis.
    Dardikh M; Meijer P; van der Meer F; Favaloro EJ; Verbruggen B
    Semin Thromb Hemost; 2012 Sep; 38(6):613-21. PubMed ID: 22740185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant: case-based external quality assessment.
    van den Besselaar AM; Devreese KM; de Groot PG; Castel A
    J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2007 Apr; 33(3):235-42. PubMed ID: 17427057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.